Home

The Center for HIV/AIDS Vaccine Immunology (CHAVI) was a consortium of universities and academic medical centers that was established by the National Institute of Allergy and Infectious Diseases (NIAID) from 2005-2012. Led by Barton Haynes, MD of Duke University, CHAVI's goal was to solve the major problems in HIV vaccine development and design. Two new Centers for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) have now been established at Duke University and at the Scripps Institute to continue to meet this goal.

Press Releases
A tribute to Norman L. Letvin (1949–2012)
Journal of Clinical Investigation
August 1, 2012
 
Timing, duration of biochemical bugle call critical for fighting viruses
Washington University School of Medicine
June 13, 2012
 
HIV hides soon after infection, UNC research shows
UNC Institute for Global Health & Infectious Diseases
May 28, 2012
See older Press Releases

Publications

Karasavvas N, Billings E, Rao M, Williams C, Zolla-Pazner S, Bailer RT, Koup RA, Madnote S, Arworn D, Shen X, Tomaras GD, Currier JR, Jiang M, Magaret C, Andrews C, Gottardo R, Gilbert P, Cardozo TJ, Rerks-Ngarm S, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Paris R, Greene K, Gao H, Gurunathan S, Tartaglia J, Sinangil F, Korber BT, Montefiori DC, Mascola JR, Robb ML, Haynes BF, Ngauy V, Michael NL, Kim JH, de Souza For The Moph Taveg Collaboration MS. The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120. AIDS Res Hum Retroviruses. 2012 Oct 4. [Epub ahead of print] Abstract

Haynes BF, Permar S. A tribute to Norman L. Letvin (1949–2012). J Clin Invest. 2012 Aug 1; 122(8): 2709-10. No abstract available.

More Publications

Announcements

Bart Haynes presents on the future of HIV-1 vaccine development
XIX International AIDS Conference
July 25, 2012